1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Dronabinol Capsules: new trials by email Literature Review of Dronabinol Capsules trials Research Report on Dronabinol Capsules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial Dronabinol Capsules, Epidiolex 100 mg/mL Oral Solution, Placebo Dronabinol - Opioid Use Disorder | Phase 3 | Not yet recruiting | Montefiore Medical Center | 40 | 2026-10-01 | 2026-06-09 |
| Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital Dronabinol Capsules, Placebo - Endometriosis, Endometriosis Related Pain | Phase 2 | Withdrawn | Baylor College of Medicine | 2026-04-01 | 2026-03-13 | |
| Oral Dronabinol-HIV Dronabinol Capsules - HIV | Phase 1 | Active not recruiting | Yale University | 160 | 2023-09-21 | 2025-11-05 |
Endometriosis (1) · Opioid-Related Disorders (1) · Pain (1)
Baylor College of Medicine (1) · Montefiore Medical Center (1) · Yale University (1)
United States (3)
Christopher Verrico, PhD in Pharmacology (1) · Deepika Slawek, MD, MPH, MS (1) · Ke Xu, MD, PhD (1)
2025 (1), R01DA052846 (1), R34DA063987 (1)